Refusal to Participate in a Randomized Trial Involving Pregnancy and Childbirth: Factors Associated with Refusal and Reasons for Refusal and Acceptance
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 24, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand why some women choose not to participate in a research study about pregnancy and childbirth. The main goal is to find out what factors might influence their decision to refuse participation, as well as to gather insights on why some women agree to take part. This research is taking place in France and is currently recruiting women aged 65 to 74 who have been invited to join a randomized trial related to their pregnancy or childbirth experience.
If you are a woman in this age group and have been approached to participate, you might be eligible to join the study. There are no specific exclusions, which means that all women offered the chance to participate are welcome to consider it. If you decide to take part, you can expect to share your thoughts and experiences regarding the invitation to join the trial. Your feedback will help researchers understand the different reasons behind acceptance and refusal, ultimately improving future studies in pregnancy and childbirth.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • The study will be offered to all women who have been offered to participate in a randomized trial relating to their pregnancy and/or childbirth in participating services.
- Exclusion Criteria:
- • None
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, Idf, France
Clamart, Idf, France
Colombes, Idf, France
Paris, Idf, France
Paris, Idf, France
Patients applied
Trial Officials
Yoann Athiel, MD
Principal Investigator
Port-Royal Maternity - APHP
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported